1. Home
  2. GAIN vs TECX Comparison

GAIN vs TECX Comparison

Compare GAIN & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gladstone Investment Corporation Business Development Company

GAIN

Gladstone Investment Corporation Business Development Company

HOLD

Current Price

$15.95

Market Cap

651.5M

Sector

Finance

ML Signal

HOLD

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$28.30

Market Cap

618.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
GAIN
TECX
Founded
2005
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
651.5M
618.9M
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
GAIN
TECX
Price
$15.95
$28.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$14.75
$75.20
AVG Volume (30 Days)
159.3K
197.6K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
9.19%
N/A
EPS Growth
20.63
40.70
EPS
0.76
N/A
Revenue
N/A
N/A
Revenue This Year
$9.07
N/A
Revenue Next Year
$7.32
N/A
P/E Ratio
$20.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.14
$14.39
52 Week High
$17.14
$39.53

Technical Indicators

Market Signals
Indicator
GAIN
TECX
Relative Strength Index (RSI) 41.22 42.68
Support Level $15.78 $27.53
Resistance Level $16.94 $31.39
Average True Range (ATR) 0.25 2.23
MACD -0.06 -0.59
Stochastic Oscillator 21.59 12.54

Price Performance

Historical Comparison
GAIN
TECX

About GAIN Gladstone Investment Corporation Business Development Company

Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S., to achieve and grow current income by investing in debt securities of established businesses, and to provide stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: